Total Payments
$71,027
2024 Payments
$292.72
Companies
16
Transactions
51
Medicare Patients
7,593
Medicare Billing
$348,329
Payment Breakdown by Category
Royalty/License$69,907 (98.4%)
Food & Beverage$1,121 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $69,907 | 2 | 98.4% |
| Food and Beverage | $1,121 | 49 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $69,907 | 2 | $0 (2019) |
| ABBVIE INC. | $395.06 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $152.96 | 8 | $0 (2024) |
| Medtronic USA, Inc. | $140.28 | 1 | $0 (2017) |
| Amgen Inc. | $82.83 | 4 | $0 (2024) |
| Allergan, Inc. | $76.03 | 5 | $0 (2020) |
| PFIZER INC. | $71.35 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $35.40 | 2 | $0 (2018) |
| Torax Medical, Inc. | $28.39 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $26.07 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $292.72 | 14 | ABBVIE INC. ($149.02) |
| 2023 | $287.51 | 13 | AbbVie Inc. ($184.91) |
| 2022 | $56.85 | 2 | ABBVIE INC. ($32.75) |
| 2021 | $43.37 | 2 | AbbVie Inc. ($28.38) |
| 2020 | $61.68 | 3 | Amgen Inc. ($27.65) |
| 2019 | $45,010 | 2 | Medtronic Vascular, Inc. ($44,989) |
| 2018 | $24,998 | 6 | Medtronic Vascular, Inc. ($24,917) |
| 2017 | $277.74 | 9 | Medtronic USA, Inc. ($140.28) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Biological | ||||||
| 08/07/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Bone Health | ||||||
| 05/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: General - Therapies_CRM | ||||||
| 02/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: GERD | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2023 | AbbVie Inc. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: VACCINES | ||||||
| 10/04/2023 | AbbVie Inc. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2023 | AbbVie Inc. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2023 | AbbVie Inc. | SYNTHROID (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: IMMUNOLOGY | ||||||
| 05/25/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: VACCINES | ||||||
| 05/03/2023 | AbbVie Inc. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,169 | 1,635 | $204,820 | $78,043 |
| 2022 | 21 | 1,905 | 2,523 | $238,985 | $91,315 |
| 2021 | 23 | 2,299 | 3,247 | $275,065 | $98,678 |
| 2020 | 24 | 2,220 | 2,988 | $247,530 | $80,292 |
Total Patients
7,593
Total Services
10,393
Medicare Billing
$348,329
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 324 | $72,900 | $30,252 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 206 | 213 | $63,900 | $26,275 | 41.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 57 | 78 | $11,310 | $5,322 | 47.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 215 | 464 | $4,640 | $3,898 | 84.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 58 | $8,700 | $3,079 | 35.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 42 | 42 | $3,150 | $3,014 | 95.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 209 | 243 | $29,160 | $2,587 | 8.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,680 | $1,277 | 76.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 23 | 25 | $2,250 | $905.28 | 40.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 25 | 26 | $1,430 | $427.96 | 29.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 27 | 27 | $1,890 | $354.24 | 18.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 30 | 30 | $2,100 | $310.50 | 14.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 30 | 30 | $1,050 | $228.30 | 21.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 33 | 33 | $660.00 | $112.53 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 294 | $66,150 | $30,563 | 46.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 204 | 205 | $61,500 | $27,571 | 44.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 72 | 73 | $5,475 | $4,984 | 91.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 73 | $10,950 | $4,901 | 44.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 21 | 21 | $3,150 | $2,774 | 88.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 196 | 221 | $26,520 | $2,509 | 9.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 72 | 73 | $2,920 | $2,420 | 82.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 145 | 181 | $12,670 | $2,384 | 18.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 125 | 140 | $7,700 | $2,308 | 30.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 29 | $4,205 | $2,292 | 54.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 150 | 198 | $13,860 | $2,057 | 14.8% |
About Dr. David Brouwer, MD
Dr. David Brouwer, MD is a Internal Medicine healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629018544.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Brouwer, MD has received a total of $71,027 in payments from pharmaceutical and medical device companies, with $292.72 received in 2024. These payments were reported across 51 transactions from 16 companies. The most common payment nature is "Royalty or License" ($69,907).
As a Medicare-enrolled provider, Brouwer has provided services to 7,593 Medicare beneficiaries, totaling 10,393 services with total Medicare billing of $348,329. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Newport Beach, CA
- Active Since 06/08/2006
- Last Updated 11/22/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629018544
Products in Payments
- VenaSeal (Device) $69,907
- UBRELVY (Drug) $310.58
- ADAPTIVESTIM (Device) $140.28
- SHINGRIX (Biological) $101.07
- QULIPTA (Drug) $85.33
- LINZESS (Drug) $41.46
- Repatha (Biological) $39.09
- AREXVY (Drug) $36.67
- PRALUENT (Drug) $35.40
- LINX (Device) $28.39
- Aimovig (Biological) $27.65
- LEQVIO (Drug) $26.07
- ELIQUIS (Drug) $23.14
- Veozah (Drug) $22.27
- PREVNAR 20 (Biological) $19.87
- NAMZARIC (Drug) $18.95
- Vascepa (Drug) $18.41
- CHANTIX (Drug) $17.26
- ESOPHYX (Device) $16.92
- JANUVIA (Drug) $16.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport Beach
Daniel Nadeau, Md, MD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Dr. Ehab Mady, D.o, D.O
Internal Medicine — Payments: $256,298
Internal Medicine $256,298
Ryan Klein, Md, MD
Internal Medicine — Payments: $159,192
Internal Medicine $159,192
Wael Harb, Md, MD
Internal Medicine — Payments: $130,572
Internal Medicine $130,572
Laura Salazar, Md, MD
Internal Medicine — Payments: $129,472
Internal Medicine $129,472
Dr. Gregory Robertson, M.d, M.D
Internal Medicine — Payments: $35,951
Internal Medicine $35,951